XML 75 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Residential Mortgage Securities and MSR-Related Assets (Tables)
3 Months Ended
Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]  
Schedule of information about MBS and CRT Securities
The following tables present certain information about the Company’s residential mortgage securities at March 31, 2020 and December 31, 2019:
 
March 31, 2020
(In Thousands)
 
Principal/ Current
Face
 
Purchase
Premiums
 
Accretable
Purchase
Discounts
 
Discount
Designated
as Credit Reserve (1)
 
Gross Amortized
Cost (2)
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Net
Unrealized
Gain/(Loss)
 
Fair 
Value
Agency MBS: (3)
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Fannie Mae
 
$
433,397

 
$
15,384

 
$
(18
)
 
$
(4,747
)
 
$
444,016

 
$
4,242

 
$

 
$
4,242

 
$
448,258

Freddie Mac
 
95,759

 
3,468

 

 
(121
)
 
99,622

 
1,655

 

 
1,655

 
101,277

Ginnie Mae
 
3,749

 
69

 

 

 
3,818

 
60

 

 
60

 
3,878

Total Agency MBS
 
532,905

 
18,921

 
(18
)
 
(4,868
)
 
547,456

 
5,957

 

 
5,957

 
553,413

Non-Agency MBS:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expected to Recover Par (4)(5)
 
150,181

 

 
(13,191
)
 

 
136,990

 
6,175

 
(21,643
)
 
(15,468
)
 
121,522

Expected to Recover Less than Par (4)
 
1,305,667

 

 
(77,777
)
 
(389,472
)
 
838,418

 
160,000

 

 
160,000

 
998,418

Total Non-Agency MBS (6)
 
1,455,848

 

 
(90,968
)
 
(389,472
)
 
975,408

 
166,175

 
(21,643
)
 
144,532

 
1,119,940

Total MBS
 
1,988,753

 
18,921

 
(90,986
)
 
(394,340
)
 
1,522,864

 
172,132

 
(21,643
)
 
150,489

 
1,673,353

CRT securities (7)
 
365,762

 
3,263

 
(42
)
 
(47,137
)
 
321,846

 

 
(67,745
)
 
(67,745
)
 
254,101

Total MBS and CRT securities
 
$
2,354,515

 
$
22,184

 
$
(91,028
)
 
$
(441,477
)
 
$
1,844,710

 
$
172,132

 
$
(89,388
)
 
$
82,744

 
$
1,927,454


December 31, 2019
(In Thousands)
 
Principal/ Current
Face
 
Purchase
Premiums
 
Accretable
Purchase
Discounts
 
Discount
Designated
as Credit Reserve (1)
 
Gross Amortized
Cost (2)
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Net
Unrealized
Gain/(Loss)
 
Fair Value
Agency MBS: (3)
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Fannie Mae
 
$
1,119,708

 
$
43,249

 
$
(22
)
 
$

 
$
1,162,935

 
$
9,799

 
$
(14,741
)
 
$
(4,942
)
 
$
1,157,993

Freddie Mac
 
480,879

 
19,468

 

 

 
500,961

 
5,475

 
(3,968
)
 
1,507

 
502,468

Ginnie Mae
 
3,996

 
73

 

 

 
4,069

 
52

 

 
52

 
4,121

Total Agency MBS
 
1,604,583

 
62,790

 
(22
)
 

 
1,667,965

 
15,326

 
(18,709
)
 
(3,383
)
 
1,664,582

Non-Agency MBS:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expected to Recover Par (4)(5)
 
722,477

 

 
(16,661
)
 

 
705,816

 
19,861

 
(9
)
 
19,852

 
725,668

Expected to Recover Less than Par (4)
 
1,472,826

 

 
(73,956
)
 
(436,598
)
 
962,272

 
375,598

 
(9
)
 
375,589

 
1,337,861

Total Non-Agency MBS (6)
 
2,195,303

 

 
(90,617
)
 
(436,598
)
 
1,668,088

 
395,459

 
(18
)
 
395,441

 
2,063,529

Total MBS
 
3,799,886

 
62,790

 
(90,639
)
 
(436,598
)
 
3,336,053

 
410,785

 
(18,727
)
 
392,058

 
3,728,111

CRT securities (7)
 
244,932

 
4,318

 
(55
)
 

 
249,195

 
6,304

 
(91
)
 
6,213

 
255,408

Total MBS and CRT securities
 
$
4,044,818

 
$
67,108

 
$
(90,694
)
 
$
(436,598
)
 
$
3,585,248

 
$
417,089

 
$
(18,818
)
 
$
398,271

 
$
3,983,519

 
(1)
Discount designated as Credit Reserve is generally not expected to be accreted into interest income. 
(2)
Includes principal payments receivable of $516,000 and $614,000 at March 31, 2020 and December 31, 2019, respectively, which are not included in the Principal/Current Face.
(3)
Amounts disclosed at March 31, 2020 and December 31, 2019 include Agency MBS with a fair value of $14.5 million and $280.3 million, respectively, for which the fair value option has been elected. Such securities had $499,000 unrealized gains and no gross unrealized losses at March 31, 2020, and $4.5 million unrealized gains and no gross unrealized losses at December 31, 2019, respectively.
(4)
Based on managements current estimates of future principal cash flows expected to be received.
(5)
Includes RPL/NPL MBS, which at March 31, 2020 had an $101.4 million Principal/Current face, $101.1 million amortized cost and $79.5 million fair value. At December 31, 2019, RPL/NPL MBS had a $632.3 million Principal/Current face, $631.8 million amortized cost and $635.0 million fair value.
(6)
At March 31, 2020 and December 31, 2019, the Company expected to recover approximately 73% and 80% of the then-current face amount of Non-Agency MBS, respectively.
(7)
Amounts disclosed at March 31, 2020 includes CRT securities with a fair value of $188.6 million for which the fair value option has been elected. Such securities had no gross unrealized gains and gross unrealized losses of approximately $67.7 million at March 31, 2020. Amounts disclosed at December 31, 2019 includes CRT securities with a fair value of $255.4 million for which the fair value option has been elected. Such securities had gross unrealized gains of approximately $6.3 million and gross unrealized losses of approximately $91,000 at December 31, 2019.
Schedule of Sale of Residential Mortgage Securities
The following table presents information about the Company’s sales of its residential mortgage securities for the three months ended March 31, 2020 and 2019. The Company has no continuing involvement with any of the sold MBS.

 
 
Three Months Ended
March 31, 2020
 
Three Months Ended
March 31, 2019
(In Thousands)
 
Sales Proceeds
 
Gains/(Losses)
 
Sales Proceeds
 
Gains/(Losses)
Agency MBS
 
$
965,132

 
$
(22,854
)
 
$

 
$

Non-Agency MBS
 
264,385

 
(43,124
)
 
126,094

 
18,153

CRT Securities
 
35,645

 
(2,017
)
 
83,368

 
6,456

Total
 
$
1,265,162

 
$
(67,995
)
 
$
209,462

 
$
24,609



Schedule of information about MBS and CRT Securities that were in an unrealized loss position
The following table presents information about the Company’s residential mortgage securities that were in an unrealized loss position at March 31, 2020, with respect to which no allowance for credit losses has been recorded:
 
Unrealized Loss Position For:
 
 
Less than 12 Months
 
12 Months or more
 
Total
 
Fair Value
 
Unrealized Losses
 
Number of Securities
Fair Value
 
Unrealized Losses
 
Number of Securities
Fair Value
 
Unrealized Losses
(Dollars in Thousands)
Agency MBS: 
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Fannie Mae
 
$

 
$

 

 
$

 
$

 

 
$

 
$

Freddie Mac
 

 

 

 

 

 

 

 

Ginnie Mae
 

 

 

 

 

 

 

 

Total Agency MBS
 

 

 

 

 

 

 

 

Non-Agency MBS:
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Expected to Recover Par (1)
 
79,464

 
21,643

 
7

 

 

 

 
79,464

 
21,643

Expected to Recover Less than Par (1)
 

 

 

 

 

 

 

 

Total Non-Agency MBS
 
79,464

 
21,643

 
7

 

 

 

 
79,464

 
21,643

Total MBS
 
79,464

 
21,643

 
7

 

 

 

 
79,464

 
21,643

CRT securities (2)
 
188,560

 
67,745

 
47

 

 

 

 
188,560

 
67,745

Total MBS and CRT securities
 
$
268,024

 
$
89,388

 
54

 
$

 
$

 

 
$
268,024

 
$
89,388



(1)
Based on management’s current estimates of future principal cash flows expected to be received.
(2)
Amounts disclosed at March 31, 2020 include CRT securities with a fair value of $188.6 million for which the fair value option has been elected. Such securities had unrealized losses of $67.7 million at March 31, 2020.

Schedule of Credit Losses
The following table presents a roll-forward of the allowance for credit losses on the Company’s Residential mortgage securities and MSR-related assets:

 
 
Three Months Ended March 31,
(Dollars In Thousands)
 
2020
 
2019
Allowance for credit losses at beginning of period
 
$

 
$

Current provision:
 

 

Securities with no prior loss allowance
 
332,756

 

Securities with a prior loss allowance
 

 

Write-offs, including allowance related to securities we intend to sell
 
(332,756
)
 

Allowance for credit losses at end of period
 
$

 
$



Schedule of changes in the components of the purchase discount on Non-Agency MBS
The following table presents the changes in the components of the Company’s purchase discount on its Non-Agency MBS between purchase discount designated as Credit Reserve and accretable purchase discount for the three months ended March 31, 2020 and 2019:

 
 
Three Months Ended
March 31, 2020
 
Three Months Ended
March 31, 2019
(In Thousands)
 
Discount
Designated as
Credit Reserve
 
Accretable
Discount
(1) 
Discount
Designated as
Credit Reserve
 
 Accretable Discount (1)
Balance at beginning of period
 
$
(436,598
)
 
$
(90,617
)
 
$
(516,116
)
 
$
(155,025
)
Impact of RMBS Issuer Settlement (2)
 

 

 

 
(855
)
Accretion of discount
 

 
9,889

 

 
13,307

Realized credit losses
 
4,459

 

 
7,504

 

Purchases
 

 

 

 
(118
)
Sales/Redemptions
 
49,491

 
(5,551
)
 
3,191

 
16,346

Net impairment losses recognized in earnings
 
(11,513
)
 

 

 

Transfers/release of credit reserve
 
4,689

 
(4,689
)
 
3,802

 
(3,802
)
Balance at end of period
 
$
(389,472
)
 
$
(90,968
)
 
$
(501,619
)
 
$
(130,147
)


(1)
Together with coupon interest, accretable purchase discount is recognized as interest income over the life of the security.
(2)
Includes the impact of $855,000 of cash proceeds (a one-time payment) received by the Company during the three months ended March 31, 2019 in connection with the settlement of litigation related to certain residential mortgage backed securitization trusts that were sponsored by JP Morgan Chase & Co. and affiliated entities.

Schedule of impact of AFS on AOCI
 
The following table presents the impact of the Company’s AFS securities on its AOCI for the three months ended March 31, 2020 and 2019:
 
 
Three Months Ended March 31,
(In Thousands)
2020
 
2019
AOCI from AFS securities:
 
 

 
 

Unrealized gain on AFS securities at beginning of period
 
$
392,722

 
$
417,167

Unrealized gain on Agency MBS, net
 
4,876

 
9,315

Unrealized gain on Non-Agency MBS, net
 
124,700

 
12,276

Unrealized (loss)/gain on MSR term notes, net
 
(5,166
)
 
512

Reclassification adjustment for MBS sales included in net income
 
(23,953
)
 
(17,009
)
Reclassification adjustment for impairment included in net income
 
(344,269
)
 

Change in AOCI from AFS securities
 
(243,812
)
 
5,094

Balance at end of period
 
$
148,910

 
$
422,261


Schedule of interest income on MBS, CRT Securities and MSR Related Assets
 
The following table presents the components of interest income on the Company’s residential mortgage securities and MSR- related assets for the three months ended March 31, 2020 and 2019
 
 
Three Months Ended March 31,
(In Thousands)
 
2020
 
2019
Agency MBS
 
 
 
 
Coupon interest
 
$
13,636

 
$
24,628

Effective yield adjustment (1)
 
(4,775
)
 
(6,187
)
Interest income
 
$
8,861

 
$
18,441

 
 
 
 
 
Legacy Non-Agency MBS
 
 
 
 
Coupon interest
 
$
17,282

 
$
24,272

Effective yield adjustment (2)
 
9,406

 
13,144

Interest income
 
$
26,688

 
$
37,416

 
 
 
 
 
RPL/NPL MBS
 
 
 
 
Coupon interest
 
$
5,583

 
$
16,443

Effective yield adjustment (1)(3)
 
280

 
142

Interest income
 
$
5,863

 
$
16,585

 
 
 
 
 
CRT securities
 
 
 
 
Coupon interest
 
$
3,485

 
$
6,118

Effective yield adjustment (2)
 
(523
)
 
82

Interest income
 
$
2,962

 
$
6,200

 
 
 
 
 
MSR-related assets
 
 
 
 
Coupon interest
 
$
14,207

 
$
10,619

Effective yield adjustment (1)
 

 
1

Interest income
 
$
14,207

 
$
10,620

 
(1)  Includes amortization of premium paid net of accretion of purchase discount.  For Agency MBS, RPL/NPL MBS and the corporate loan secured by MSRs, interest income is recorded at an effective yield, which reflects net premium amortization/accretion based on actual prepayment activity.
(2) The effective yield adjustment is the difference between the net income calculated using the net yield, which is based on management’s estimates of the amount and timing of future cash flows, less the current coupon yield.
(3) Includes accretion income recognized due to the impact of redemptions of certain securities that had been previously purchased at a discount of approximately $277,000 and $148,000 during the three months ended March 31, 2020 and 2019, respectively.